Prevalence of Sarcopenia in Geriatric Patients
Completed
- Conditions
- Sarcopenia
- Registration Number
- NCT04124575
- Lead Sponsor
- University Department of Geriatric Medicine FELIX PLATTER
- Brief Summary
To assess the prevalence of sarcopenia among inpatients on acute geriatrics and geriatric rehabilitation wards of a Swiss university department of geriatric medicine using the most recent diagnosis definitions from european guidelines.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 350
Inclusion Criteria
- All patients >65 years old admitted to acute geriatrics and geriatric rehabilitation at the study site
Exclusion Criteria
- Lack of informed written consent
- Implanted defibrillation device
- Acute Sepsis, severe volume overload or dehydration
- Life expectancy of < 3 months according to treating physician
- Unremovable bandages
- Patients in isolation rooms on the ward
- Measurement is not possible due to organizational reasons
- Inability to follow the procedures, e.g. due to language problems, psychological disorders
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Presence of Sarcopenia (yes/no) Baseline Using EWGSOP2 cut-off points
Muscle quantity, measured by Body Impedance Analysis (kg) Baseline Gait Speed (m/s) Baseline Timed up and go Test (s) Baseline Hand Grip Strength (kPa) Baseline
- Secondary Outcome Measures
Name Time Method Mini Mental Status (Score range from 0 to 30 Points; higher scores reflect better cognitive status) Baseline Calf and Mid-upper arm Circumference (cm) Baseline Nutritional risk Screening (Score range from 0 to 7 Points; higher scores reflect higher risk of malnutrition) Baseline Body Mass Index (kg/m^2) Baseline Weight and height will be combined to report Body Mass Index in kg/m\^2
Geriatric Depression Scale short version (Score range from 0 to 6 Points; higher scores reflect higher risk of depression) Baseline Functional Independence Measure at Admission (Score range from 18 to 126 Points; higher scores reflect better functionality) Baseline
Trial Locations
- Locations (1)
University Department of Geriatric Medicine FELIX PLATTER
🇨ðŸ‡Basel, Switzerland